The Kurume Medical Journal · 1971 · 14 citations · 7 references
PharmacyPharmacotherapyPsychiatryNeuropharmacologyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapySchizophrenia PharmacotherapySchizophrenia Spectrum DisordersTreatment Of Mental DisordersAntipsychotic ActionAntipsychotic Medication UseDopaminergic Drug-induced PsychosisDopaminergic Therapy ManagementOral Antipsychotic TherapyPsychostimulant Pharmacotherapy
In three cases of schizophrenia, ill for three-six years with no sign of remission under various psychopharmacotherapies, L-Dopa was used with the major tranquilizers which had previously been used. Subsequently, remarkable recovery was noted. The tentative dosage of L-Dopa in this research was 400-1200 mg per day. Hallucination and thought disorder had disappeared as well as apathy and lack of spontaneity. In one case, upon the suspension of L-Dopa, the patient's symptoms exacerbated. Continuous administration of L-Dopa is necessary for the improvement of the symptoms.
7
Distribution of catechol compounds in human brain
Isamu Sano, Tatsuzo Gamo, Yasuo Kakimoto et al. · Biochimica et Biophysica Acta · 1959 · 261 citations
EFFECT OF L-DOPA ON DEPRESSION
WilliamE. Bunney, DavidS. Janowsky, FrederickK. Goodwin et al. · The Lancet · 1969 · 64 citations
Medicine, Neuroscience, Pharmacology +12
L-Dopa therapy in Parkinson's disease.
Melvin Greer · PubMed · 1970 · 44 citations
Medicine, Neurology, Pharmacology +12
EFFECTS OF L‐DOPA ON PHARMACOLOGICAL PARKINSONISM
A. Bbrung, Savino Bruno · Acta Psychiatrica Scandinavica · 1966 · 42 citations
Medicine, Neuroscience, Pharmacology +10